Immupath pooled plasma: As part of a three-protocol Phase III trial
HEMA is scheduled to meet with the FDA on June 27 to discuss the company's plan to
Gathering data...
HEMA is scheduled to meet with the FDA on June 27 to discuss the company's plan to